A powerful solution for 360-degree portfolio analysis and commercial forecasting
A powerful solution for 360-degree portfolio analysis and commercial forecasting
It is a project portfolio and forecasting solution generating highly accurate and reliable forecasts that inform strategic decisions throughout your product’s lifecycle. Whether choosing the best asset development plan, mapping market entry strategies, navigating access and reimbursement landscapes, or optimizing supply chain operations, Clairvoyance equips you with foresight to drive commercial success.
Clairvoyance automates project data integration, data aggregation and summarization of crucial portfolio metrics and insights, all in one consolidated dashboard offering a consolidated view of the project portfolio for senior executives.
Additionally, it can also provide crucial financial and operational metrics such as project delivery milestone dates, development cost forecast, and revenue forecasts, with appropriate risk adjustments based on Probability of Technical and Regulatory Success (PTRS) and potential market events. The framework is technology agnostic and can be fully customized as per the organization’s unique requirements.
Clairvoyance offers a consolidated view of all the projects within the portfolio, providing senior executives a powerful tool for data-driven decision-making.
Precision in forecasting key financial and operational metrics such as project delivery milestone dates, development cost forecast, and revenue forecasts.
Get visibility into aggregate risks (clinical, regulatory, commercial) at each risk gate in your development cycle to understand costs and timing decisions.
Clairvoyance helps portfolio leaders remove bias from decision making, whether it is patient forecast or revenue forecasts.
Clairvoyance offers significant advantages for large pharmaceutical enterprises by streamlining and enhancing the management of their extensive project portfolios. By automating project data integration and aggregation, Clairvoyance ensures that senior executives have access to accurate and up-to-date information in a single, consolidated dashboard.
The platform’s ability to provide reliable forecasts for development costs, revenue, and milestone dates, adjusted for technical and regulatory success probabilities, equips executives with the foresight needed to allocate resources effectively, prioritize high-value projects, and mitigate risks.
For small biotech firms, Clairvoyance provides a critical edge by delivering high-quality insights and forecasts that are typically out of reach for smaller organizations with limited resources. By consolidating project data and presenting crucial financial and operational metrics in an intuitive dashboard, Clairvoyance enables small biotech companies to make data-driven decisions with confidence.
The ability to forecast development costs and potential revenues, while adjusting for risks associated with technical and regulatory success, ensures that small biotech companies can manage their limited resources efficiently, attract investment, and strategically plan their growth.
Clairvoyance offers significant advantages for large pharmaceutical enterprises by streamlining and enhancing the management of their extensive project portfolios. By automating project data integration and aggregation, Clairvoyance ensures that senior executives have access to accurate and up-to-date information in a single, consolidated dashboard.
The platform’s ability to provide reliable forecasts for development costs, revenue, and milestone dates, adjusted for technical and regulatory success probabilities, equips executives with the foresight needed to allocate resources effectively, prioritize high-value projects, and mitigate risks.
For small biotech firms, Clairvoyance provides a critical edge by delivering high-quality insights and forecasts that are typically out of reach for smaller organizations with limited resources. By consolidating project data and presenting crucial financial and operational metrics in an intuitive dashboard, Clairvoyance enables small biotech companies to make data-driven decisions with confidence.
The ability to forecast development costs and potential revenues, while adjusting for risks associated with technical and regulatory success, ensures that small biotech companies can manage their limited resources efficiently, attract investment, and strategically plan their growth.
Clairvoyance helps life sciences R&D, and Commercialization leaders to improve portfolio performance and achieve accurate revenue forecasting resulting in data-driven decisions and assured return on investments even in the most uncertain times.
One executive dashboard to turn every risk into an opportunity
Enhanced Decision-
Making
Empower the leadership team with consolidated data to monitor and evaluate project performance and development scenarios.
Increased
Efficiency &
Productivity
Automated data aggregation & report generation saves valuable time to focus on strategic initiatives.
Advanced
Risk
Management
Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio.
Greater
Transparency &
Accountability
Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.
Scalability
& Future-
Readiness
Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.
Enhance your drug commercialization strategies with the power of data quickly and accurately
i2e’s proprietary forecasting solution, Clairvoyance, helps deliver higher accuracy and reliability in your forecasting across all lifecycle decisions: market entry, access and reimbursement, and supply chain management.
Our forecasting suite for BioPharma distills the most valuable insights for you generated by our best-in-class forecasting engine driven through industry relevant analytics, data, and domain expertise.
Evidence based decision making
Whether it is pricing or lead candidate demand estimation, make evidence-based decisions led by domain relevant data and our proprietary algorithms.
Insights
Manage supply chain risks, pre-empt distribution blind spots, and communicate your insights confidently to executive stakeholders through our intuitive forecast communication and interactive BI dashboards.
Flexibility
We help you manage high-volume high-velocity data, customize it and integrate influencing variables such as market and economic trends and reduce data overwhelm and fatigue.
Whether it is dynamic scenario analysis or driving therapeutic innovation, Clairvoyance can accelerate your forecasting accuracy driving growth, value, and revenue.
Improve R&D productivity through our Live innovation Benchmarking Bench to Market
Assess portfolio augmentation opportunities, drive asset prioritization for licensing and other partnering opportunities.
Evaluate market share impact, monitor key competitive threats, assess and augment eNPV.
One executive dashboard to turn every risk into an opportunity
Empower the leadership team with consolidated data to monitor and evaluate project performance and development scenarios
Automated data aggregation & report generation saves valuable time to focus on strategic initiatives
Empower the leadership team with consolidated data to monitor and evaluate project performance
Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio.
Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.
Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.
Enhance your drug commercialization strategies with the power of data quickly and accurately
i2e’s proprietary forecasting solution, Clairvoyance, helps deliver higher accuracy and reliability in your forecasting across all lifecycle decisions: market entry, access and reimbursement, and supply chain management.
Our forecasting suite for BioPharma distills the most valuable insights for you generated by our best-in-class forecasting engine driven through industry relevant analytics, data, and domain expertise.
Whether it is pricing or lead candidate demand estimation, make evidence-based decisions led by domain relevant data and our proprietary algorithms.
Manage supply chain risks, pre-empt distribution blind spots, and communicate your insights confidently to executive stakeholders through our intuitive forecast communication and interactive BI dashboards.
We help you manage high-volume high-velocity data, customize it and integrate influencing variables such as market and economic trends and reduce data overwhelm and fatigue.
Whether it is dynamic scenario analysis or driving therapeutic innovation, Clairvoyance can accelerate your forecasting accuracy driving growth, value, and revenue.
Improve R&D productivity through our Live innovation Benchmarking Bench to Market
Assess portfolio augmentation opportunities, drive asset prioritization for licensing and other partnering opportunities.
Evaluate market share impact, monitor key competitive threats, assess and augment eNPV.
One executive dashboard to turn every risk into an opportunity
Be it investment allocations within your R&D portfolio to reduce risks and have a positive impact on the overall organization’s performance, or strategically balancing product investments in the short-term and long-term.
i2e’s Clairvoyance eliminates data disparity and provides a single digital dashboard of crucial project-level data.
Empower the leadership team with consolidated data to monitor and evaluate project performance and development scenarios
Automated data aggregation & report generation saves valuable time to focus on strategic initiatives
Empower the leadership team with consolidated data to monitor and evaluate project performance
Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio.
Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.
Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.
Enhance your drug commercialization strategies with the power of data quickly and accurately
i2e’s proprietary forecasting solution, Clairvoyance, helps deliver higher accuracy and reliability in your forecasting across all lifecycle decisions: market entry, access and reimbursement, and supply chain management.
Our forecasting suite for BioPharma distills the most valuable insights for you generated by our best-in-class forecasting engine driven through industry relevant analytics, data, and domain expertise.
Whether it is pricing or lead candidate demand estimation, make evidence-based decisions led by domain relevant data and our proprietary algorithms.
Manage supply chain risks, pre-empt distribution blind spots, and communicate your insights confidently to executive stakeholders through our intuitive forecast communication and interactive BI dashboards.
We help you manage high-volume high-velocity data, customize it and integrate influencing variables such as market and economic trends and reduce data overwhelm and fatigue.
Whether it is dynamic scenario analysis or driving therapeutic innovation, Clairvoyance can accelerate your forecasting accuracy driving growth, value, and revenue.
Improve R&D productivity through our Live innovation Benchmarking Bench to Market
Assess portfolio augmentation opportunities, drive asset prioritization for licensing and other partnering opportunities.
Evaluate market share impact, monitor key competitive threats, assess and augment eNPV.
One executive dashboard to turn every risk into an opportunity
Be it investment allocations within your R&D portfolio to reduce risks and have a positive impact on the overall organization’s performance, or strategically balancing product investments in the short-term and long-term.
i2e’s Clairvoyance eliminates data disparity and provides a single digital dashboard of crucial project-level data.
Empower the leadership team with consolidated data to monitor and evaluate project performance and development scenarios
Automated data aggregation & report generation saves valuable time to focus on strategic initiatives
Empower the leadership team with consolidated data to monitor and evaluate project performance
Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio.
Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.
Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.
Consolidated Portfolio view of Projects that enables visibility into composition and performance and informs strategic decisions on investment scenarios.
Gain clarity into long range project and portfolio profitability and contrast growth scenarios with different portfolio compositions.
Compare and Contrast evaluation scenarios with key metrics for projects approaching investment decision milestones.
Comprehensive forecast model includes predictions of key metrics such as patient numbers, sales, and pre-launch expenses spanning from launch to patient expiration.
A single source of truth for all expected revenue forecast metrics for your drugs enabling quick and accurate strategic commercialization initiatives.
Clairvoyance provides a seamless integration providing a secure pathway to integrate your internal spreadsheets, databases, and applications creating an accurate and holistic view into your portfolio.
Upload data from your existing excel sheets containing data about your entire portfolio.
Source data from your enterprise project & portfolio systems
Portfolio data is integrated for fast dashboard visualization.
Offers smooth and secure integration with internal database or third-party applications
Be it investment allocations within your R&D portfolio to reduce risks and have a positive impact on the overall organization’s performance, or strategically balancing product investments across short-term and long-term opportunities, R&D decision makers need to evaluate the risks, opportunities, interdependencies and alternative scenarios across the portfolio to make confident decisions
i2e’s Clairvoyance eliminates data disparity and provides a digital dashboard of crucial project-level data.
Empower the leadership team with consolidated data to monitor and evaluate project performance
Automated data aggregation & report generation saves valuable time to focus on strategic initiatives
Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio.
Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.
Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.
With Clairvoyance you will have a comprehensive dashboard built to support critical conversations during portfolio reviews by providing an overview of pivotal financial data such as eNPV, production index, PTRS.
Seamless integration with existing project management tools, and third-party tools related to research, finance
Automated pulling of real-time data saves time and ensures accuracy and consistency
A holistic view of the entire project portfolio vital metrics via intuitive dashboard
Display KPIs’ though charts, graphs, and tables for quick access to project status
Ability to facilitate stakeholders to collaborate on analysis feedback and insights during prioritization and decision making
Capability to drill down deeper into individual projects for more detailed analysis
Direct access to project-specific reports, research findings, financial forecasts, etc
Robust notification system to alert on significant changes, or potential risks in specific projects
Ability to conduct scenario analysis and sensitivity tests within the dashboard offering quick access to each project’s performance
Clairvoyance provides a seamless integration providing a secure pathway to integrate your internal spreadsheets, databases, and applications creating an accurate and holistic view into your portfolio.
93 Shennecossett Rd, Suite # 104, Groton, CT 06340
+1(866) 968-9995
solutions@i2econsulting.com
Talk to our expert!
Carlos Nunes
Vice President – Portfolio Management and digital Innovation
Carlos joined i2e from a 25-year career experience as an industry consultant and a pharma insider in strategic portfolio management and digital innovation. He is an industry pioneer in designing and deploying enterprise integrated, real-time executive decision support tools to enable data-driven R&D asset investment analysis, scenario planning and portfolio sustainability.
